GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » G Medical Innovations Holdings Ltd (FRA:9GM0) » Definitions » EV-to-Revenue

G Medical Innovations Holdings (FRA:9GM0) EV-to-Revenue : 0.73 (As of Jun. 24, 2024)


View and export this data going back to 2017. Start your Free Trial

What is G Medical Innovations Holdings EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, G Medical Innovations Holdings's enterprise value is €3.05 Mil. G Medical Innovations Holdings's Revenue for the trailing twelve months (TTM) ended in Dec. 2022 was €4.18 Mil. Therefore, G Medical Innovations Holdings's EV-to-Revenue for today is 0.73.

The historical rank and industry rank for G Medical Innovations Holdings's EV-to-Revenue or its related term are showing as below:

FRA:9GM0's EV-to-Revenue is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 3.02
* Ranked among companies with meaningful EV-to-Revenue only.

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-06-24), G Medical Innovations Holdings's stock price is €0.068. G Medical Innovations Holdings's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2022 was €5.45. Therefore, G Medical Innovations Holdings's PS Ratio for today is 0.01.


G Medical Innovations Holdings EV-to-Revenue Historical Data

The historical data trend for G Medical Innovations Holdings's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

G Medical Innovations Holdings EV-to-Revenue Chart

G Medical Innovations Holdings Annual Data
Trend Sep16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
EV-to-Revenue
Get a 7-Day Free Trial 5,059.43 2,385.28 13,824.98 5.58 2.17

G Medical Innovations Holdings Semi-Annual Data
Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13,824.98 - 5.58 - 2.17

Competitive Comparison of G Medical Innovations Holdings's EV-to-Revenue

For the Medical Instruments & Supplies subindustry, G Medical Innovations Holdings's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


G Medical Innovations Holdings's EV-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, G Medical Innovations Holdings's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where G Medical Innovations Holdings's EV-to-Revenue falls into.



G Medical Innovations Holdings EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

G Medical Innovations Holdings's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=3.048/4.177
=0.73

G Medical Innovations Holdings's current Enterprise Value is €3.05 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. G Medical Innovations Holdings's Revenue for the trailing twelve months (TTM) ended in Dec. 2022 was €4.18 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


G Medical Innovations Holdings  (FRA:9GM0) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

G Medical Innovations Holdings's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=0.068/5.445
=0.01

G Medical Innovations Holdings's share price for today is €0.068.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Dec. 2022 was €5.45.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


G Medical Innovations Holdings EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of G Medical Innovations Holdings's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


G Medical Innovations Holdings (FRA:9GM0) Business Description

Traded in Other Exchanges
N/A
Address
5 Oppenheimer Street, Rehovot, ISR, 7670105
G Medical Innovations Holdings Ltd is a mobile health (mHealth), telemedicine solutions, and monitoring service platforms. It develops and markets clinical and consumer medical-grade health monitoring solutions and offers end-to-end support for e-health projects. The company offers a suite of both consumer and clinical grade products and platforms which are positioned to reduce inefficiencies in healthcare delivery, improve access, reduce costs, increase the quality of care, and make healthcare more personalized and precise. Its operating segment includes Products, Patient Services, and Covid-19 testing. The company generates maximum revenue from the Patient Services segment.

G Medical Innovations Holdings (FRA:9GM0) Headlines

No Headlines